[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BiotechAnalysst "$SGMO and Astellas: rAAV Gene Therapies for RARE NEURO Diseases re "Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases" #STAC_BBB"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-10 16:04:25 UTC 4057 followers, 4336 engagements

"$KILL the other day: "Executive Leadership Appointments In conjunction with the restructuring $KILL announced key executive appointments:" next day: Another patient has died the company confirmed this time in an other study. they obviously never looked for a better capsid"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-18 11:55:45 UTC 4057 followers, XXX engagements

"$XBI Biggest Biotech Outflows in Years ($1.546B of net outflows last week) but $CRSP insider buys for 50milli (or half a $SGMO marketcap)"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-18 13:35:47 UTC 4046 followers, 2459 engagements

"$sgmo Said has dmd cure ready in fridge Roche should dump $srpt and go all in $sgmo. As for sangamo it was always patients first"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-19 19:04:02 UTC 4060 followers, 2756 engagements

"this shows that the capsid and cargo construct is most important and can lead to lower dosing needs in GT VS $SRPT needs very high doses leading to death of patients leader in CAPSIDS is $SGMO also Sangamo cargo constructs are clean + safe with 100s of years of clinical data"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-20 11:27:31 UTC 4049 followers, 6664 engagements

"top XXX monogenic diseases $SGMO can cure ranked by patient populations mutation-specific targetability existing treatment status commercial impact & likelihood of insurance reimbursement. Literally limitless potential here thanks the the science of @SangamoTx HT/@alamentarius"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-27 16:00:16 UTC 4060 followers, 5801 engagements

"#Roche slide on neuro development is RG6434 $SGMO"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-24 08:39:19 UTC 4049 followers, 3642 engagements

"$ARWR Arrowhead Pharmaceuticals Earns $XXX Million Milestone from $SRPT Sarepta Therapeutics 💸"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-28 12:04:50 UTC 4060 followers, 1175 engagements

"#Astellas says "We see #more platform #development together with (them) Sangamo $SGMO to actually create the next generation of gene therapy .#neuromuscular disease strategy"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-10 16:18:02 UTC 4058 followers, 6158 engagements

"$XBI Chart of the Week: Nektar looking long in the tooth $NKTR is now in its 35th year of drug development without marketing its own product joining the likes of $SGMO + $CYTK in longest product development cycles. a chance to beat $IMGN ImmunoGen's 40-plus year record"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-06-27 06:46:45 UTC 4060 followers, 5504 engagements

"#Astellas say #gene #editing might be next . $SGMO Astellas is doubling down on gene therapy Building an end-to-end AAV platform from research to commercial Strategic partnerships driving CNS and rare disease programs"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-17 14:08:03 UTC 4059 followers, 3442 engagements

"$SRPT should they change company name and their ticker to just start over what ticker suits this company best"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-18 11:41:26 UTC 4054 followers, 1085 engagements

"#Point72 (Steven A Cohen) bought 750k $SGMO calls"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-22 08:44:47 UTC 4060 followers, 9302 engagements

"Barclays $SRPT negative CHMP opinion and FDA commentary raised concerns on timing and possibility of Elevidys return to mkt. It raises *** major liquidity issue *** even with further cost-cutting. #Downgrade to UW PT $10"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-28 09:00:06 UTC 4060 followers, 2054 engagements

"$BBIO KOL Webinar Highlights Expectations for BBP-418's Ph3 Interim Analysis in 2H25 trends toward stabilization on functional measures should suffice for #AA and broad uptakewe see XXX as a free call option at current levels"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-11 18:41:09 UTC 4053 followers, 1705 engagements

"glad to see FDA pulling $SRPT #platform tech #designation .Sarepta platform is bad tech and killing people. $SGMO platform XXX% clean safty in 100s of patients over decades. $SGMO deserves multiple platform designations. expect full support of FDA for Sangamo safe tech"
@BiotechAnalysst Avatar @BiotechAnalysst on X 2025-07-20 09:21:45 UTC 4049 followers, 4561 engagements